Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Bullboard Posts
Comment by labumbaon Nov 22, 2006 2:25pm
200 Views
Post# 11730345

RE: belatacept? ..antoninus.

RE: belatacept? ..antoninus.the article you posted is about a phase2 trial result as below: " The findings from a Phase II clinical trial of belatacept, conducted in 218 patients at 22 centers in the U.S., Canada and Europe between March 2001 and December 2003, are published in the August 25 issue of the New England Journal of Medicine. Christian P. Larsen, MD, PhD, director of the Emory Transplant Center and professor of surgery at Emory University School of Medicine, and Flavio Vincenti, MD, of the University of California, San Francisco, are co-lead authors of the article. " ------------------------------------------------- At present Bristal-Myers is recruiting patients undergoing kidney transplant for a phase3 trial. Theoretically, you are talking about a noval drug in phase 2 status and it is still too soon to conclude
Bullboard Posts